Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Relapse
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(10)
+
-
Availability
Open access
(4)
+
-
Metadata Only
(6)
+
-
Creation Date
2017
(3)
+
-
2013
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(10)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(10)
+
-
Topic
Relapse
(10)
+
-
Recurrence
(3)
+
-
Remission
(2)
+
-
Author
Beuers, U.
(2)
+
-
Biezen, A. van
(2)
+
-
Bouma, G.
(2)
+
-
Brouwer, J.T.
(2)
+
-
Buuren, H.R. van
(2)
+
-
Drenth, J.P.H.
(2)
+
-
Erpecum, K.J. van
(2)
+
-
Gelderblom, H.
(2)
+
-
Guichelaar, M.M.J.
(2)
+
-
Hoek, B. van
(2)
+
-
Koek, G.H.
(2)
+
-
Mulder, C.J.J.
(2)
+
-
Ouden, J.W. den
(2)
+
-
Verdonk, R.C.
(2)
+
-
Show more
Language
en
(10)
+
-
Search results
(1 - 10 of 10)
show grid
show list
save search
Effects up to 20-Year follow-up of preventive cognitive therapy in adults remitted from recurrent depression
Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis
Response Assessment in Myeloma: Practical Manual on Consistent Reporting in an Era of Dramatic Therapeutic Advances
Treatment consumption and treatment re-enrollment in GHB-dependent patients in The Netherlands
Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse
Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis
Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission
Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis
Survival after recurrent osteosarcoma: Data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials